Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sopharma AD Earnings Release 2023

May 22, 2023

2543_rns_2023-05-22_a049fd41-cf93-4406-91cf-aa76be8e1e80.pdf

Earnings Release

Open in viewer

Opens in your device viewer

Current report №24/2023 Dated May 22, 2023

NOTIFICATION

"Sopharma" AD (the Company) notifies that for April 2023 the Company realized a decrease in sales of 22% compared to the same month of the previous year, including 5% decrease of domestic sales and 31% decrease of export sales.

For the four months of 2023, sales increased by a total of 24% - maintaining domestic sales and 47% growth of export sales.

Ognian Donev